Interaction of nitric oxide synthase inhibitors and their D-enantiomers with rat neutrophil luminol dependent chemiluminescence response

British Journal of Pharmacology

Volumn 119, Issue 3, 1996, Pages 578-582

  Dikshit, M ^a   Chari, S S ^a   Seth, P ^a   Kumari, R ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Cytochrome c reduction; L arginine analogues; Luminol and lucigenin dependent chemiluminescence; Myeloperoxidase; Oxygen consumption; Polymorphonuclear leukocytes

Indexed keywords

ARACHIDONIC ACID; CYTOCHROME C; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LUCIGENIN; LUMINOL; MYELOPEROXIDASE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENANTIOMER; MALE; NEUTROPHIL; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT;

EID: 0029809391     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15711.x     Document Type: Article

References (36)

1. ANTONINI, J.M., DYKE, K.V., YE, Z., DIMATTO, M. & REASOR, M.J. (1994). Introduction of Luminol dependent chemiluminescence as a method to study silica inflammation in the tissue and phagocytic cells of rat lung. Environ. Health Perspect, 102 (Suppl 10), 37-42.
2. G-monomethyl-L-arginine causes nitric oxide synthesis in isolated arterial rings: Trouble in paradise. Biochem. Biophys. Res. Commun., 188, 590-596.
3. BABIOR, B.M. & COHEN, H.J. (1981). Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. In Leukocyte Function. ed. Cline M.J. pp. 39-72. New York: Churchill Livingstone.
4. BELENKY, S.N., ROBBINS, R.A. & RUBINSTEIN, I. (1993). Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J. Leukocyte Biol., 53, 498-503.
5. BOYUM, A. (1968). Isolation of granulocyte cells and lymphocytes from human blood. Scan. J. Lab. Invest., 21 (Suppl 97), 77-89.
6. G nitro-L-arginine-methyl ester and other alkyl ester of arginine are muscarinic receptor antagonists. Circ. Res., 12, 387-395.
7. CARRERAS, M.C., PARGAMENT, G.A., CATZ, S.D., PODEROSO, J.J. & BOVERIS, A. (1994). Kinectics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils. FEBS Lett., 341, 65-68.
8. CHEN, L.Y., LAWSON, D.L. & MEHTA, J.L. (1994). Reduction in human neutrophil superoxide anion generation by N-3 polyunsaturated fatty acids: Role of cyclooxygenase products and endothelium-derived relaxing factor. Thrombosis Res., 76, 317-322.
9. CLANCY, R.M., LESZCZYNSKA-PIZIAK, J. & ABRAMSON, S.B. (1992). Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest., 90, 1116-1121.
10. DEWALD, B.M., BAGGIOLINI, J.T., CURNUTTE, J.T. & BABIOR, B.M. (1979). Subcellular localization of the superoxide forming enzymes in human neutrophils. J. Clin. Invest., 63, 21-29.
11. DIKSHIT, M., KUMARI, R. & SRIMAL, R.C. (1992). Effect of pulmonary thromboemoblism on circulating neutrophils in mice. Thrombosis Res., 66, 133-139.
12. DIKSHIT, M., KUMARI, R. & SRIMAL, R.C. (1993). Pulmonary thromboembolism induced alteration in nitric oxide release from rat circulating neutrophils. J. Pharmacol. Exp. Ther., 265, 1369-1372.
13. DING, J., LU, D.J., PEREZSALA, D., MA, Y.T., MADDOX, J.F., GILBERT, B.A., BADWEY, J.A. & RANDO, R.R. (1994). Farnesy-L-Cysteine analogues can inhibit or initiate superoxide release by human neutrophils. J. Biol. Chem., 269, 16837-16844.
14. GREENERG, S.S., XIE, J., SPITZER, J.J., WANG, J., LANCASTER, J., GRISHAM, M.B., POWERS, D.R. & GILES, T.D. (1995). Nitro containing L-arginine analogs interfere with assays for nitrate and nitrite. Life Sci., 57, 1949-1961.
15. HECKER, M., BARA, A.T., BAUERSACHS, J. & BUSSE, R. (1994). Characterization of endothelial-derived hyperpolarizing factor as a cytochrome metabolite in mammals. J. Physiol., 481, 407-414.
16. G-monomethyl-L-arginine: a role for cyclic GMP. Blood, 74, 1885-1887.
17. KUBES, P.M., SUZUKI, M. & GRANGER, D.N. (1991). Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U.S.A., 88, 4651-4655.
18. MALAWISTA, S.E., MONTGOMERY, R.R. & BLARICOM, G.V. (1992). Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts. A new microbicidal pathway for polymorphonuclear leukocytes. J. Clin. Invest., 90, 631-636.
19. MCCALL, T.B., FEELISH, M., PALMER, R.M. & MONCADA, S. (1991). Identification of N-iminoethyl-L-ornithine (NIO) as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br. J. Pharmacol., 102, 234-238.
20. MITAKA, C., HIRATA, C., ICHIKAWA, K. VCHIDA, T., YOKOYAMA, K., NAGURA, T., TSUNODO, Y & AMAHA, K. (1995). Effects of nitric oxide synthase inhibitor on hemodynamic change and oxygen delivery in septic dogs. Am. J. Physiol., 268, H2017-H2023.
21. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43, 109-142.
22. NAKAIKE, R., SHIMOKAWA, H., YASUTAKE, H., SUMIMOTO, H., ITO, A., NUMAGUCHI, K., EGASHIRA, K., TAKESHIGE, K. & TAKESHITA, A. (1995). Effects of L-arginine analogs on vasomotion of isolated porcine coronary arteries. Am. J. Physiol., 268, H1966-H1972.
23. O'MURCHU, B., MILLER, V.M., PERRELLA, M.A. & BURNETT, J.C. Jr. (1994). Increased production of nitric oxide in coronary arteries during congestive heart failure. J. Clin. Invest., 93, 165-171.
24. PETERSON, D.A. (1992). The nonspecificity of specific nitric oxide synthase inhibitors. Biochem. Biophys. Rex. Commun., 187, 797-801.
25. PIPER, G.M., CLARK, G.A. & GROSS, G.J. (1994). Stimulatory and inhibitory action of nitric oxide donor agents vs nitrovasodilators on reactive oxygen production by isolated polymorphonuclear leukocytes. J. Pharmacol. Exp. Ther., 269, 451-456.
26. POU, S., POU, W.S., BREDT, D.S., SYNDER, S.H. & ROSEN, G.H. (1992). Generation of Superoxide by purified brain nitric oxide synthase. J. Biol. Chem., 267, 24173-24176.
27. RUBYANI, G.M., HO, E.H., CANTOR, E.H., LUMMA, W.C. & BOTELHO, L.H.P. (1991). Cytoprotective function of nitric oxide: Inactivation of superoxide radiacls produced by human leukocytes. Biochem. Biophys. Res. Commun., 181, 1392-1397.
28. SCHMIDT, K., KLATT, P. & MAYER, B. (1993). Characterization of endothelial cell amino acid transport systems involved in the action of nitric oxide synthase inhibitors. Mol. Pharmacol., 44, 615-621.
29. SCHMIDT, K., KLATT, P. & MAYER, B. (1994). Uptake of nitric oxide synthase inhibitors by macrophage RAW 264.7 cells. Biochem. J., 301, 313-316.
30. SETH, P., KUMARI, R., DIKSHIT, M. & SRIMAL, R.C. (1994). Modulation of rat peripheral polymorphonuclear leukocyte response by nitric oxide and arginine. Blood, 84, 2741-2748.
31. 2-induced endothelial cell injury. Br. J. Pharmacol., 113, 564-568.
32. SIMONET, S., BAILLIENCOURT, J.P.D., DESCOMBES, J.J., MENNECIER, P., LAUBIE, M. & VERBEUREN, T. (1993). Hypoxia causes an abnormal contractile response in the atherosclerotic rabbit aorta - Implication of reduced nitric oxide and cGMP production. Circ. Res., 72, 616-630.
33. TAKAHASHI, R., EDASHIQE, K., SATO, E.F., INOUE, M., MATSUNO, T. & UTSUMI, K. (1991). Luminol chemiluminscence and active oxygen generation by activated neutrophils. Arch. Biochem. Biophys., 285, 325-330.
34. G-monomethyl L-arginine. J. Pharmacol. Exp. Ther., 260, 676-679.
35. VANHEEL, B., VAN DEVOORDE, J. & LEUSEN, I. (1994). Contribution of nitric oxide to the endothelium dependent hyperpolarization in the rat aorta. J. Physiol., 475, 277-284.
36. 3H] arginine in cultured neurones: Characteristics and inhibition by nitric oxide synthase inhibitors. J. Neurochem., 61, 364-367.